Literature DB >> 25348113

Prophylactic effect of H2 blocker for anastomotic stricture after esophageal atresia repair.

Naruhiko Murase1, Hiroo Uchida1, Kenitiro Kaneko1, Yasuyuki Ono1, Satoshi Makita1, Kazuki Yokota1.   

Abstract

BACKGROUND: Anastomotic stricture is the main complication after esophageal atresia (EA) repair. In this study, we assessed the efficacy of long-term prophylactic H2 blocker treatment in preventing stricture.
METHODS: Twenty-seven patients who had undergone primary repair for EA (Gross type C) were reviewed retrospectively. The patients were analyzed in two groups: the H2 blocker group (n = 13), in which the patients were treated with prophylactic H2 blocker; and the control group (n = 14), in which they were not. To assess anastomotic stricture, contrast esophagography was performed and the number of patients who required balloon dilatation was recorded.
RESULTS: Five patients (18.5%) required postoperative balloon dilatation within 1 year of primary repair. There was no difference in dilatation rate between the two groups. In the H2 blocker group, however, anastomotic stricture improved significantly in the late postoperative period relative to that in the early postoperative period. In contrast, in the control group, anastomotic stricture did not improve after a long postoperative period. The incidence of gastroesophageal reflux was 55.6%. Postoperative gastroesophageal reflux was a predisposing factor for balloon dilatation in the control group, but not in the H2 blocker group.
CONCLUSIONS: Long-term treatment with prophylactic H2 blocker may prevent anastomotic stricture caused by gastroesophageal reflux in the late postoperative period after EA repair.
© 2014 The Authors. Pediatrics International published by Wiley Publishing Asia Pty Ltd on behalf of Japan Pediatric Society.

Entities:  

Keywords:  anastomotic stricture; balloon dilatation; esophageal atresia; gastroesophageal reflux; prophylactic H2 blocker

Mesh:

Substances:

Year:  2015        PMID: 25348113     DOI: 10.1111/ped.12529

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Comparison of outcomes of thoracoscopic primary repair of gross type C esophageal atresia performed by qualified and non-qualified surgeons.

Authors:  Yujiro Tanaka; Takahisa Tainaka; Wataru Sumida; Chiyoe Shirota; Naruhiko Murase; Kazuo Oshima; Ryo Shirotsuki; Kosuke Chiba; Hiroo Uchida
Journal:  Pediatr Surg Int       Date:  2017-08-11       Impact factor: 1.827

Review 2.  How to Care for Patients with EA-TEF: The Known and the Unknown.

Authors:  Hayat Mousa; Usha Krishnan; Maheen Hassan; Luigi Dall'Oglio; Rachel Rosen; Frédéric Gottrand; Christophe Faure
Journal:  Curr Gastroenterol Rep       Date:  2017-11-25

3.  Evaluation of the intraoperative risk factors for esophageal anastomotic complications after primary repair of esophageal atresia with tracheoesophageal fistula.

Authors:  Yuichi Okata; Kosaku Maeda; Yuko Bitoh; Yasuhiko Mishima; Akihiko Tamaki; Keiichi Morita; Kosuke Endo; Chieko Hisamatsu; Hiroaki Fukuzawa; Akiko Yokoi
Journal:  Pediatr Surg Int       Date:  2016-07-26       Impact factor: 1.827

Review 4.  Fibronectin glomerulopathy complicated with persistent cloaca and congenital esophageal atresia: a case report and literature review.

Authors:  Misaki Takii; Takaichi Suehiro; Aya Shima; Hideki Yotsueda; Satoshi Hisano; Ritsuko Katafuchi
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

Review 5.  Are prophylactic anti-reflux medications effective after esophageal atresia repair? Systematic review and meta-analysis.

Authors:  Hiromu Miyake; Yong Chen; Alison Hock; Shogo Seo; Yuhki Koike; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2018-03-13       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.